Marshall Wace North America’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $501K | Sell |
6,274
-89,106
| -93% | -$7.12M | ﹤0.01% | 1080 |
|
|
2021
Q2 | $9.29M | Buy |
+95,380
| New | +$9.29M | 0.04% | 388 |
|
|
2020
Q2 | – | Sell |
-154
| Closed | -$10K | – | 1340 |
|
|
2020
Q1 | $10K | Buy |
+154
| New | +$10K | ﹤0.01% | 1162 |
|
|
2019
Q2 | – | Sell |
-141,301
| Closed | -$17.7M | – | 1412 |
|
|
2019
Q1 | $17.7M | Buy |
+141,301
| New | +$17.7M | 0.13% | 156 |
|
|
2018
Q3 | – | Sell |
-34,985
| Closed | -$9.79M | – | 1186 |
|
|
2018
Q2 | $9.79M | Buy |
+34,985
| New | +$9.79M | 0.06% | 339 |
|
|
2018
Q1 | – | Sell |
-45,785
| Closed | -$4.2M | – | 1584 |
|
|
2017
Q4 | $4.2M | Buy |
+45,785
| New | +$4.2M | 0.02% | 634 |
|